Sajjanar Mangala, Sajjan Parappa, Puranik Rudrayya S, Vanaki Shreenivas, Jayanth V, Naik Pooja
Department of Oral Pathology, Mallareddy Institute of Dental Sciences, Hyderabad, Telangana, India.
Department of Public Health Dentistry, Mallareddy Institute of Dental Sciences, Hyderabad, Telangana, India.
J Oral Maxillofac Pathol. 2020 Sep-Dec;24(3):499-504. doi: 10.4103/jomfp.JOMFP_154_19. Epub 2021 Jan 9.
Oral squamous cell carcinoma (OSCC) accounts for more than 90% of all oral cancers. Epidermal growth factor receptor (EGFR) dysregulation is associated with essentially all of the key features of cancer. Tissue microarrays (TMAs) allow the simultaneous analysis of many tumours using small-diameter cores sampled from larger blocks of tissue. Hence present study was taken up to validate TMA technology.
To analyse and compare the immunohistochemical (IHC) expression of EGFR in OSCC using TMA technology and in whole tissue sections.
Study included 34 cases of OSCC.Three tissue cores, each 1 mm in diameter were placed into a recipient paraffin block using a precision microarray instrument finally containing 102 spots. EGFR expression was analysed. Agreement between whole sections and TMA scores was analysed using Cohen's weighted Kappa.
EGFR expression was seen in 61.8% of whole section cases. In TMA out of 102 cores 75.50 % of the disks were confirmed to represent an adequate amount of tumor tissue. In TMA 48.5% cases showed EGFR expression.The EGFR expression of whole.
Some OSCC express high EGFR and this expression may be an independent Wfactor of certain clinico-pathological variables. TMA may be used as an adjunct with conventional method of evaluation of OSCC especially in larger sample sized studies keeping in mind its limitations.
口腔鳞状细胞癌(OSCC)占所有口腔癌的90%以上。表皮生长因子受体(EGFR)失调与癌症的所有关键特征基本相关。组织微阵列(TMA)允许使用从较大组织块中采样的小直径芯同时分析许多肿瘤。因此,本研究旨在验证TMA技术。
使用TMA技术和全组织切片分析并比较EGFR在OSCC中的免疫组织化学(IHC)表达。
研究包括34例OSCC。使用精密微阵列仪器将三个直径为1毫米的组织芯放入一个最终包含102个斑点的受体石蜡块中。分析EGFR表达。使用科恩加权卡帕分析全切片和TMA评分之间的一致性。
61.8%的全切片病例中可见EGFR表达。在TMA中,102个芯中有75.50%的切片被证实含有足够量的肿瘤组织。在TMA中,48.5%的病例显示EGFR表达。全组织的EGFR表达情况。
一些OSCC表达高EGFR,这种表达可能是某些临床病理变量的独立因素。考虑到TMA的局限性,它可作为评估OSCC的传统方法的辅助手段,特别是在样本量较大的研究中。